M
M. Harrington
Researcher at National Institutes of Health
Publications - 3
Citations - 4325
M. Harrington is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 4315 citations.
Papers
More filters
Journal ArticleDOI
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
Anthony S. Fauci,John G. Bartlett,Eric P. Goosby,M. D. Smith,H. J. Kaiser,S. W. Chang,James M. Anderson,R. Armstead,A. C. Baker,David A Barr,Samuel A. Bozzette,S. Cox,M. Delaney,Fred M. Gordin,W. Greaves,M. Harrington,J. J. Henning,Martin S. Hirsch,J. Jacobs,Richard Marlink,C. Maxwell,J. W. Mellors,D. B. Nash,S. Perryman,Robert T. Schooley,R. Sherer,Stephen A. Spector,G. Torres,Paul A. Volberding,B. A. Brady,E. M. Daniels,D. Feigal,Mark B. Feinberg,H. D. Gayle,T. R. Graydon,Jonathan E. Kaplan,Abe M. Macher,R. F. Martin,Henry Masur,Lynne M. Mofenson,J. Murray,J. O'Neill,L. C. Perez,R. Riseberg,S. Shekar,Sharilyn K. Stanley,J. Whitescarver +46 more
TL;DR: These Guidelines were developed by the Panel* on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services and the Henry J. Kaiser Family Foundation.
Journal ArticleDOI
The 1/4/6x24 campaign to cure tuberculosis quickly
Lindsay McKenna,Mike Frick,Ketholelie Angami,Vuyiseka Dubula,Jennifer Furin,M. Harrington,Harry Hausler,Petra Heitkamp,Rosa Herrera,Sharonann Lynch,Carole D. Mitnick,Gloriah Kerubo Moses,Norbert Ndjeka,Bern-Thomas Nyang'wa,Lindsay Palazuelos,Patrick Ulysse,Madhukar Pai +16 more
Journal ArticleDOI
One-year incidence of tuberculosis infection and disease among household contacts of rifampin- and multi-drug resistant tuberculosis.
Sonya Krishnan,Xingye Wu,Soyeon Kim,Katherine N. McIntire,Linda Naini,Michael Hughes,Rodney Dawson,Vidya Mave,Sanjay Gaikwad,Jorge Torres Sánchez,Alberto Mendoza-Ticona,Pedro Gonzales,Kyla Comins,Justin Shenje,Sandy Nerette Fontain,A. Omozoarhe,Lerato Mohapi,Umesh G. Lalloo,A. C.Garcia Ferreira,Christopher Mugah,M. Harrington,N. Sarita Shah,Anneke C. Hesseling,Gavin J. Churchyard,Susan Swindells,Amita Gupta +25 more
TL;DR: In this article , the authors conducted a cross-sectional study of HHCs of rifampin/multidrug-resistant tuberculosis in 8 high-burden countries and re-assessed TBI (interferon-gamma release assay, HHC ≥5 years) and TBD (HHCs all ages) at one-year.